GB201910608D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201910608D0
GB201910608D0 GBGB1910608.7A GB201910608A GB201910608D0 GB 201910608 D0 GB201910608 D0 GB 201910608D0 GB 201910608 A GB201910608 A GB 201910608A GB 201910608 D0 GB201910608 D0 GB 201910608D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1910608.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enterprise Therapeutics Ltd
Original Assignee
Enterprise Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterprise Therapeutics Ltd filed Critical Enterprise Therapeutics Ltd
Priority to GBGB1910608.7A priority Critical patent/GB201910608D0/en
Publication of GB201910608D0 publication Critical patent/GB201910608D0/en
Priority to JP2022504580A priority patent/JP7682850B2/ja
Priority to EP20751239.3A priority patent/EP4003977B1/en
Priority to PCT/GB2020/051785 priority patent/WO2021014172A1/en
Priority to CN202080053457.2A priority patent/CN114929683B/zh
Priority to US17/581,520 priority patent/US12545658B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1910608.7A 2019-07-24 2019-07-24 Compounds Ceased GB201910608D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1910608.7A GB201910608D0 (en) 2019-07-24 2019-07-24 Compounds
JP2022504580A JP7682850B2 (ja) 2019-07-24 2020-07-24 カルシウム活性化クロライドチャネルモジュレーターとしてのピリジン誘導体
EP20751239.3A EP4003977B1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as calcium-activated chloride channel modulators
PCT/GB2020/051785 WO2021014172A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as calcium-activated chloride channel modulators
CN202080053457.2A CN114929683B (zh) 2019-07-24 2020-07-24 作为钙激活氯化物通道调节剂的吡啶衍生物
US17/581,520 US12545658B2 (en) 2019-07-24 2022-01-21 Pyridine derivatives as calcium-activated chloride channel modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1910608.7A GB201910608D0 (en) 2019-07-24 2019-07-24 Compounds

Publications (1)

Publication Number Publication Date
GB201910608D0 true GB201910608D0 (en) 2019-09-04

Family

ID=67839705

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1910608.7A Ceased GB201910608D0 (en) 2019-07-24 2019-07-24 Compounds

Country Status (6)

Country Link
US (1) US12545658B2 (https=)
EP (1) EP4003977B1 (https=)
JP (1) JP7682850B2 (https=)
CN (1) CN114929683B (https=)
GB (1) GB201910608D0 (https=)
WO (1) WO2021014172A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2291749A1 (fr) * 1974-11-20 1976-06-18 Delalande Sa Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
US6262040B1 (en) * 1996-09-04 2001-07-17 Pfizer Inc Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF)
CA2419224A1 (en) * 2000-09-15 2002-03-21 Anormed Inc. Chemokine receptor binding heterocyclic compounds
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
US9550737B2 (en) * 2012-06-11 2017-01-24 Ucb Biopharma Sprl TNF -α modulating benzimidazoles
US9458124B2 (en) * 2013-02-06 2016-10-04 Wayne State University Substituted pyran derivatives
AU2016247768B2 (en) * 2015-04-17 2019-03-07 Corteva Agriscience Llc Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
HUE064145T2 (hu) * 2016-04-15 2024-03-28 Epizyme Inc Amin-szubsztituált aril- vagy heteroaril vegyületek, mint EHMT1 és EHMT2 inhibitorok
GB201610854D0 (en) * 2016-06-21 2016-08-03 Entpr Therapeutics Ltd Compounds
GB201619694D0 (en) * 2016-11-22 2017-01-04 Entpr Therapeutics Ltd Compounds
AU2018211529A1 (en) * 2017-01-27 2019-08-29 Genfit N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxa zin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
US11358947B2 (en) * 2017-04-17 2022-06-14 The Regents Of The University Of California Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds

Also Published As

Publication number Publication date
CN114929683A (zh) 2022-08-19
US20220144803A1 (en) 2022-05-12
EP4003977B1 (en) 2026-04-15
JP7682850B2 (ja) 2025-05-26
EP4003977A1 (en) 2022-06-01
WO2021014172A1 (en) 2021-01-28
US12545658B2 (en) 2026-02-10
CN114929683B (zh) 2024-09-03
JP2022541638A (ja) 2022-09-26

Similar Documents

Publication Publication Date Title
IL289463A (en) Agonist-gipr compounds
GB201913603D0 (en) New compounds
GB201905721D0 (en) Compounds
GB201910305D0 (en) Compounds
GB201916915D0 (en) Compounds
GB201908536D0 (en) Compounds
GB201912404D0 (en) New compounds
GB201910304D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201919205D0 (en) Compounds
GB201918761D0 (en) Compounds
GB201918424D0 (en) Compounds
GB201917895D0 (en) Compounds
GB201917893D0 (en) Compounds
GB201917891D0 (en) Compounds
GB201916847D0 (en) Compounds
GB201916572D0 (en) Compounds
GB201916597D0 (en) Compounds
GB201916595D0 (en) Compounds
GB201916142D0 (en) Compounds
GB201914208D0 (en) Compounds
GB201913633D0 (en) Compounds
GB201913541D0 (en) Compounds
GB201912850D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)